Your browser doesn't support javascript.
loading
E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
Bruijstens, Arlette L; Wendel, Eva-Maria; Lechner, Christian; Bartels, Frederik; Finke, Carsten; Breu, Markus; Flet-Berliac, Lorraine; de Chalus, Aliénor; Adamsbaum, Catherine; Capobianco, Marco; Laetitia, Giorgi; Hacohen, Yael; Hemingway, Cheryl; Wassmer, Evangeline; Lim, Ming; Baumann, Matthias; Wickström, Ronny; Armangue, Thaís; Rostasy, Kevin; Deiva, Kumaran; Neuteboom, Rinze F.
Afiliação
  • Bruijstens AL; Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: a.bruijstens@erasmusmc.nl.
  • Wendel EM; Department of Paediatrics, Klinikum Stuttgart/Olgahospital, Stuttgart, Germany.
  • Lechner C; Department of Paediatrics, Division of Paediatric Neurology, Medical University of Innsbruck, Austria.
  • Bartels F; Department of Neurology, Charité - Universitätsmedizin Berlin / Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Germany.
  • Finke C; Department of Neurology, Charité - Universitätsmedizin Berlin / Berlin School of Mind and Brain, Humboldt-Universität zu Berlin, Germany.
  • Breu M; Department of Paediatrics and Adolescent Medicine, Division of Paediatric Neurology, Medical University of Vienna, Austria.
  • Flet-Berliac L; Department of Paediatric Neurology, Assistance Publique-Hôpitaux de Paris, University Hospitals Paris-Saclay, Bicêtre Hospital and Faculty of Medicine, Paris-Saclay University, Le Kremlin Bicêtre, France.
  • de Chalus A; Department of Paediatric Neurology, Assistance Publique-Hôpitaux de Paris, University Hospitals Paris-Saclay, Bicêtre Hospital and Faculty of Medicine, Paris-Saclay University, Le Kremlin Bicêtre, France.
  • Adamsbaum C; Paediatric Radiology Department, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, University Hospitals Paris-Saclay, Bicêtre Hospital and Faculty of Medicine, Paris-Saclay University, Le Kremlin Bicêtre, France.
  • Capobianco M; Department of Neurology and Regional Multiple Sclerosis Centre, University Hospital San Luigi Gonzaga, Orbassano, Italy.
  • Laetitia G; Department of Paediatric Neurology, Assistance Publique-Hôpitaux de Paris, University Hospitals Paris-Saclay, Bicêtre Hospital and Faculty of Medicine, Paris-Saclay University, Le Kremlin Bicêtre, France.
  • Hacohen Y; Department of Neuroinflammation, Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology / Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, UK.
  • Hemingway C; Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, UK.
  • Wassmer E; Department of Paediatric Neurology, Birmingham Children's Hospital, Birmingham, UK.
  • Lim M; Children's Neurosciences, Evelina London Children's Hospital at Guy's and St Thomas' National Health Service Foundation Trust, London, Faculty of Life Sciences and Medicine, Kings College Hospital, London, UK.
  • Baumann M; Department of Paediatrics, Division of Paediatric Neurology, Medical University of Innsbruck, Austria.
  • Wickström R; Neuropaediatric Unit, Karolinska University Hospital, Sweden.
  • Armangue T; Neuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Paediatric Neuroimmunology Unit, Neurology Department, Sant Joan de Déu (SJD) Children's Hospital, University of Barcelona, Barcelona, Spain.
  • Rostasy K; Department of Paediatric Neurology, Children's Hospital Datteln, Witten/Herdecke University, Datteln, Germany.
  • Deiva K; Department of Paediatric Neurology, Assistance Publique-Hôpitaux de Paris, University Hospitals Paris-Saclay, Bicêtre Hospital and Faculty of Medicine, Paris-Saclay University, Le Kremlin Bicêtre, France; French Reference Network of Rare Inflammatory Brain and Spinal Diseases, Le Kremlin Bicêtre, Fr
  • Neuteboom RF; Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands.
Eur J Paediatr Neurol ; 29: 41-53, 2020 Nov.
Article em En | MEDLINE | ID: mdl-33176999

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes Desmielinizantes do Sistema Nervoso Central / Glicoproteína Mielina-Oligodendrócito Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Male Idioma: En Revista: Eur J Paediatr Neurol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes Desmielinizantes do Sistema Nervoso Central / Glicoproteína Mielina-Oligodendrócito Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Male Idioma: En Revista: Eur J Paediatr Neurol Ano de publicação: 2020 Tipo de documento: Article